Abstract 1051: Endothelial CEPT1 Impacts Aortic Atherosclerosis And Hepatic Lipoprotein Metabolism

Abstract

Background: Circulating lipids that contribute to the development of atherosclerosis are derived from very low-density lipoprotein (VLDL), produced in liver by a process requiring microsomal triglyceride transfer protein (MTTP). Since choline ethanolamine phosphotransferase 1 (CEPT1) generates phospholipids critical for membrane composition and signaling, we hypothesized that Cept1 deficiency reduces hepatic MTTP and aortic atherosclerosis. Methods: Conditional endothelial cell (EC)-specific knockdown of Cept1 ( Cept1 fl/fl Cre+ ) was performed in ApoE -/- mice maintained on a 42% high-fat diet for 12 weeks, serum lipids were measured, and aorta, aortic roots, and liver tissue were harvested (Figure, A). In addition, EC-hepatocyte (HepG2 cells) signaling was evaluated using an in vitro co-culture assay, and Mttp gene expression was assessed in HepG2 cells, cultured with and without ECs treated with Cept1 siRNA (Figure, B and C). Results: Compared to ApoE -/- mice, Cept1 fl/fl Cre+ ApoE -/- mice had significantly reduced serum cholesterol (P < .05; Figure, D) and triglyceride (P < .01; Figure, E), and reduced atherosclerotic lesions of the aorta and aortic root (P < .01 and P < .05, respectively; Figure, F-I). Cept1 fl/fl Cre+ ApoE -/- mice also demonstrated more severe hepatic steatosis and numerically greater content of liver lipid droplets (Figure, J and K). Cept1 knockdown in ECs co-cultured with HepG2 cells resulted in a significant decrease in Mttp expression (P < .01; Figure, L). Conclusion: Our findings suggest that deficiency of endothelial Cept1 significantly reduces aortic atheroprogression. This may, in part, be due to a reduction in serum lipid levels via inhibition of hepatocyte MTTP driven by signals from endothelial cells. These findings open a new avenue of exploration regarding the influence of EC signaling on hepatic lipid metabolism and its impact on hyperlipidemia and atherosclerotic cardiovascular diseases.